MA
PFE icon

Marshwinds Advisory’s Pfizer PFE Stock Holding History

Marshwinds Advisory’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$5.06M Sell
122,140
-4,472
-4% -$186K 2.71% 4
2018
Q3 		$5.29M Sell
126,612
-2,785
-2% -$107K 2.42% 6
2018
Q2 		$4.45M Sell
129,397
-522
-0.4% -$17.8K 2.11% 8
2018
Q1 		$4.38M Sell
129,919
-94
-0.1% -$3.23K 2.08% 11
2017
Q4 		$4.47M Sell
130,013
-2,685
-2% -$91.6K 2.07% 10
2017
Q3 		$4.5M Buy
132,698
+3
+0% +$96 2.09% 8
2017
Q2 		$4.23M Sell
132,695
-1,495
-1% -$47.1K 2% 13
2017
Q1 		$4.36M Sell
134,190
-150
-0.1% -$4.73K 2.03% 12
2016
Q4 		$4.14M Sell
134,340
-343
-0.3% -$10.5K 1.97% 11
2016
Q3 		$4.33M Sell
134,683
-803
-0.6% -$26.9K 2.11% 8
2016
Q2 		$4.53M Sell
135,486
-765
-0.6% -$24.4K 2.2% 7
2016
Q1 		$3.83M Sell
136,251
-1,892
-1% -$54K 1.97% 11
2015
Q4 		$4.23M Sell
138,143
-6,553
-5% -$206K 2.21% 9
2015
Q3 		$4.31M Buy
144,696
+418
+0.3% +$13.4K 2.31% 7
2015
Q2 		$4.59M Sell
144,278
-7,510
-5% -$245K 2.31% 7
2015
Q1 		$5.01M Sell
151,788
-221
-0.1% -$7.03K 2.37% 6
2014
Q4 		$4.49M Sell
152,009
-784
-0.5% -$22.5K 2.12% 9
2014
Q3 		$4.29M Buy
152,793
+633
+0.4% +$17.8K 2.12% 12
2014
Q2 		$4.29M Buy
152,160
+206
+0.1% +$5.87K 2.06% 11
2014
Q1 		$4.63M Buy
151,954
+338
+0.2% +$10.1K 2.34% 7
2013
Q4 		$4.41M Sell
151,616
-2,650
-2% -$77.1K 2.33% 8
2013
Q3 		$4.2M Buy
154,266
+213
+0.1% +$5.79K 2.42% 9
2013
Q2 		$4.09M Buy
+154,053
New +$4.26M 2.43% 6

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshwinds Advisory's PFE Position: Q4 2018 in Review

Marshwinds Advisory reduced its Pfizer (PFE) stake by 3.5% in Q4 2018, selling an estimated $186K and leaving 122,140 shares worth $5.06M. The position accounts for 2.71% of the portfolio, ranked #4.

Marshwinds Advisory first reported a position in PFE in Q2 2013 and has held it in 23 quarters since. The position peaked at $5.29M in Q3 2018. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Marshwinds Advisory held 122,140 shares of Pfizer worth $5.06M as of Q4 2018.
  • Marshwinds Advisory sold 4,472 Pfizer shares in Q4 2018, an estimated $186K.
  • Pfizer made up 2.71% of Marshwinds Advisory's portfolio in Q4 2018, its #4 holding.
  • Marshwinds Advisory first reported a position in Pfizer in Q2 2013 and has held it in 23 quarters since.
  • Marshwinds Advisory's Pfizer position peaked at $5.29M in Q3 2018.
  • 2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Marshwinds Advisory's 13F filing for Q4 2018, filed 7 Jan 2019.